Close



Feb 27, 2024 06:00AM
Feb 26, 2024 06:00AM
Nov 9, 2023 04:01PM
Sep 19, 2023 06:15AM
Aug 2, 2023 06:00AM
Jul 12, 2023 07:00AM
Nov 9, 2022 07:00AM BeiGene Reports Third Quarter 2022 Financial Results
Aug 4, 2022 07:00AM
Jul 14, 2022 06:00AM
Jun 13, 2022 07:00AM
May 5, 2022 07:00AM
Apr 11, 2022 06:00AM
Mar 11, 2022 07:00AM
Feb 25, 2022 07:00AM BeiGene Reports Fourth Quarter and Full Year 2021 Financial Results
Feb 22, 2022 07:00AM
Jan 24, 2022 05:00AM
Jan 6, 2022 06:38AM
Jan 6, 2022 03:30AM
Dec 20, 2021 06:15AM
Dec 10, 2021 06:15AM
Dec 10, 2021 03:00AM BeiGene Presents Results from Phase 3 Trial of Tislelizumab in Nasopharyngeal Cancer at ESMO Immuno-Oncology Congress 2021
Dec 2, 2021 11:00PM
Nov 4, 2021 04:05PM
Sep 13, 2021 06:18AM
Sep 13, 2021 12:00AM
Aug 5, 2021 04:05PM
May 19, 2021 07:01AM
May 19, 2021 07:00AM BeiGene Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for BRUKINSA® (Zanubrutinib) in Marginal Zone Lymphoma
Feb 25, 2021 04:05PM
Feb 17, 2021 07:05AM
Feb 17, 2021 07:00AM

12,344 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All